Download PDF

Satellite Symposium:

New Biomarkers for Early Risk Assessment of AKI: Solving the Challenge

  • Location: Horta Room
  • Chairperson: John Kellum (Pittsburgh, USA)
  • Time: March 20, 2013 at 12:30

Programme (12:30-13:30)
  •  Welcome and Introduction - John Kellum (Pittsburgh, USA)
  •  Cell Cycle Arrest Biomarkers for AKI - Lakhmir Chawla (Washington, USA)
  •  Pathogenesis of AKI - John Kellum (Pittsburgh, USA)
  •  Implications for Management of AKI - Andrew Shaw (Durham, USA)
  •  Questions and Answers

About Astute Medical

Astute Medical is committed to improving patient outcomes through the identification and validation of unique, new biomarkers. Our measurement methods help rapidly assess high-risk acute medical problems and diseases. By incorporating useful clinical tools, we help health care professionals more readily perform risk assessment for elderly and critically ill patients. And because our tools produce test results for risk assessment within minutes, they position physicians to provide rapid, accurate and life-saving responses.

To find out more please visit Astute Medical at ISICEM 2013, stand nr. 2.65 - 2.68 or visit: www.astutemedical.com/Europe

«« BioPorto Diagnostics at ISICEM 2013


Edwards Lifesciences at ISICEM 2013 »»


AKI, Biomarkers, ISICEM2013, AstuteMedical

Latest Articles

  • Pharmacist in the ICU

    Pharmacists play a crucial role in the ICU, where patients often require complex medication regimens, including multiple medications and intravenous therapies. The role of a critical care pharmacist is multifaceted and vital to ensuring optimal patient care in the critical care setting.   Cr

    READ MORE
  • Defining Medicines Optimisation in the Intensive Care Unit

      Complex polypharmacy and pathophysiology are common in the intensive care unit (ICU). Medicines optimisation is essential to deliver safe, effective, and individualised pharmacotherapy. This is ideally performed by a specialised ICU pharmacist.   Introduction Medicines ar

    READ MORE
  • Critical Care Pharmacists Save Lives

      The purpose of this review is to discuss the role of critical care pharmacists on the interprofessional healthcare team in the care of critically ill patients and explore current gaps in the provision of comprehensive medication management.   Introduction   “The patient’s

    READ MORE
AKI, Biomarkers, ISICEM2013, AstuteMedical Satellite Symposium: New Biomarkers for Early Risk Assessment of AKI: Solving the ChallengeLocation: Horta RoomChairperson: John Kellum (Pittsburgh, USA)T...